Results 331 to 340 of about 157,909 (342)

Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer

Ca-A Cancer Journal for Clinicians, 2016
Baris Turkbey, Anna Laucis, Sandeep Sankineni   +2 more
exaly  

Towards a systems understanding of MHC class I and MHC class II antigen presentation

Nature Reviews Immunology, 2011
Jacques J C Neefjes, Petra Paul, Oddmund Bakke   +2 more
exaly  

Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Jesse K Mckenney, A Oliver Sartor, Howard Sandler   +2 more
exaly  

Screening for Prostate Cancer

Ca-A Cancer Journal for Clinicians, 2009
Donna Pauler Ankerst, Ian M Thompson Jr
exaly  

Prostate-specific antigen: current status

Ca-A Cancer Journal for Clinicians, 1999
exaly  

Monocyte differentiation and antigen-presenting functions

Nature Reviews Immunology, 2017
Claudia V Jakubzick, Gwendalyn J Randolph, Peter M Henson   +2 more
exaly  

Prostate-Specific Antigen and Premalignant Change: Implications for Early Detection

Ca-A Cancer Journal for Clinicians, 1989
exaly  

Expectant management for men with early stage prostate cancer

Ca-A Cancer Journal for Clinicians, 2015
Christopher Filson, Mark S Litwin
exaly  

How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma

Ca-A Cancer Journal for Clinicians, 1995
exaly  

Unproven Methods of Cancer Treatment: Rand Coupled Fortified Antigen (RCFA) and Delayed Double Diffusion (3-D) Test

Ca-A Cancer Journal for Clinicians, 1969
exaly